首页> 美国卫生研究院文献>Cancer Science >Chemokine (C‐X‐C motif) ligand 1 and CXCL2 produced by tumor promote the generation of monocytic myeloid‐derived suppressor cells
【2h】

Chemokine (C‐X‐C motif) ligand 1 and CXCL2 produced by tumor promote the generation of monocytic myeloid‐derived suppressor cells

机译:肿瘤产生的趋化因子(C‐X‐C基序)配体1和CXCL2促进单核细胞来源的抑制细胞的生成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Accumulation of myeloid‐derived suppressor cells (MDSC) in tumor‐bearing hosts is a hallmark of tumor‐associated inflammation, which is thought to be a barrier to immunosurveillance. Multiple factors secreted by tumor cells and tumor stromal cells are reported to be involved in promoting the expansion of MDSC. Herein, we showed that s.c. inoculation of tumor cells and i.v. injection of tumor‐conditioned medium increased the number of MDSC. Subsequent investigation elucidated that chemokine (C‐X‐C motif) ligand 1 (CXCL1) and CXCL2, which were originally characterized as the chemokines of neutrophils, specifically promoted the expansion of monocytic MDSC (mo‐MDSC), a subtype of MDSC, in the presence of granulocyte‐macrophage colony‐stimulating factor. Depletion of CXCL1 or CXCL2 in B16F10 cells or in B16F10‐bearing mice noticeably decreased the generation of mo‐MDSC in bone marrow. Moreover, we found that, in addition to the tumor cells, tumor‐infiltrated CD11b+ myeloid cells also expressed CXCL1 and CXCL2. Furthermore, CXCL1‐ and CXCL2‐induced increase of mo‐MDSC was not correlated with chemotaxis, proliferation or apoptosis of mo‐ style="fixed-case">MDSC. These findings show a novel role of style="fixed-case">CXCL1 and style="fixed-case">CXCL2 in promoting mo‐ style="fixed-case">MDSC generation by favoring the differentiation of bone marrow cells in tumor‐bearing conditions, which suggests that inhibition of style="fixed-case">CXCL1 and style="fixed-case">CXCL2 could decrease mo‐ style="fixed-case">MDSC generation and improve host immunosurveillance.
机译:携带肿瘤的宿主中髓样来源的抑制细胞(MDSC)的积累是肿瘤相关炎症的标志,被认为是免疫监测的障碍。据报道,由肿瘤细胞和肿瘤基质细胞分泌的多种因子参与促进MDSC的扩增。在这里,我们显示了接种肿瘤细胞和静脉注射肿瘤条件培养基会增加MDSC的数量。随后的研究表明,最初被表征为嗜中性粒细胞趋化因子的趋化因子(C‐X‐C基序)配体1(CXCL1)和CXCL2,特别促进了单核细胞MDSC(mo‐MDSC)的扩增。粒细胞巨噬细胞集落刺激因子的存在。 B16F10细胞或带有B16F10的小鼠中CXCL1或CXCL2的耗竭明显减少了骨髓中mo-MDSC的生成。此外,我们发现,除肿瘤细胞外,肿瘤浸润的CD11b + 髓样细胞还表达CXCL1和CXCL2。此外,CXCL1和CXCL2诱导的mo-MDSC的增加与mo- style =“ fixed-case”> MDSC 的趋化性,增殖或凋亡无关。这些发现表明 style =“ fixed-case”> CXCL 1和 style =“ fixed-case”> CXCL 2在促进mo- style =“ fixed -case“> MDSC 的产生通过促进荷瘤条件下骨髓细胞的分化,这表明抑制 style =” fixed-case“> CXCL 1和 style = “ fixed-case”> CXCL 2可以减少mo- style =“ fixed-case”> MDSC 的产生并改善宿主免疫监测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号